Current best clinical practices for monitoring of interstitial lung disease.
Elizabeth BendstrupSissel Kronborg-WhiteJanne MøllerThomas Skovhus PriorPublished in: Expert review of respiratory medicine (2023)
Due to the high heterogeneity of the ILDs and their disease course, an individualized multimodality approach must be applied. Future strategies include use of telemedicine for home monitoring of lung function and symptoms, use of artificial intelligence to support automatized guidance of patients, computerized evaluation of ILD changes on imaging, and new imaging tools with less radiation dosage.
Keyphrases
- interstitial lung disease
- artificial intelligence
- lung function
- systemic sclerosis
- end stage renal disease
- high resolution
- healthcare
- rheumatoid arthritis
- machine learning
- big data
- chronic obstructive pulmonary disease
- primary care
- idiopathic pulmonary fibrosis
- chronic kidney disease
- newly diagnosed
- deep learning
- ejection fraction
- prognostic factors
- peritoneal dialysis
- current status
- photodynamic therapy
- patient reported outcomes
- radiation induced
- clinical decision support
- mass spectrometry
- electronic health record